|
Rating |
| Note (1): For VA
compensation purposes, diagnostic imaging studies include, but are
not limited to, conventional radiography (X-ray), computed
tomography (CT), magnetic resonance imaging (MRI), positron
emission tomography (PET), radionuclide bone scanning, or
ultrasonography |
|
| Note (2):
Separately evaluate loss of vocal articulation, loss of smell, loss
of taste, neurological impairment, respiratory dysfunction, and
other impairments under the appropriate diagnostic code and combine
under § 4.25 for each separately rated condition |
|
| 9900 Maxilla or
mandible, chronic osteomyelitis, osteonecrosis or
osteoradionecrosis of: |
|
| Rate as
osteomyelitis, chronic under diagnostic code 5000. |
|
| 9901 Mandible,
loss of, complete, between angles |
100 |
| 9902 Mandible,
loss of, including ramus, unilaterally or bilaterally: |
|
| Loss of
one-half or more, |
|
| Involving
temporomandibular articulation |
|
| Not replaceable
by prosthesis |
70 |
| Replaceable by
prosthesis |
50 |
| Not involving
temporomandibular articulation. |
|
| Not replaceable
by prosthesis |
40 |
| Replaceable by
prosthesis |
30 |
| Loss of less
than one-half, |
|
| Involving
temporomandibular articulation. |
|
| Not replaceable
by prosthesis |
70 |
| Replaceable by
prosthesis |
50 |
| Not involving
temporomandibular articulation. |
|
| Not replaceable
by prosthesis |
20 |
| Replaceable by
prosthesis |
10 |
| 9903 Mandible,
nonunion of, confirmed by diagnostic imaging studies: |
|
| Severe, with
false motion |
30 |
| Moderate,
without false motion |
10 |
| 9904 Mandible,
malunion of: |
|
| Displacement,
causing severe anterior or posterior open bite |
20 |
| Displacement,
causing moderate anterior or posterior open bite |
10 |
| Displacement,
not causing anterior or posterior open bite |
0 |
| 9905
Temporomandibular disorder (TMD): |
|
| Interincisal
range: |
|
| 0 to 10
millimeters (mm) of maximum unassisted vertical opening. |
|
| With dietary
restrictions to all mechanically altered foods |
50 |
| Without dietary
restrictions to mechanically altered foods |
40 |
| 11 to 20 mm of
maximum unassisted vertical opening. |
|
| With dietary
restrictions to all mechanically altered foods |
40 |
| Without dietary
restrictions to mechanically altered foods |
30 |
| 21 to 29 mm of
maximum unassisted vertical opening. |
|
| With dietary
restrictions to full liquid and pureed foods |
40 |
| With dietary
restrictions to soft and semi-solid foods |
30 |
| Without dietary
restrictions to mechanically altered foods |
20 |
| 30 to 34 mm of
maximum unassisted vertical opening. |
|
| With dietary
restrictions to full liquid and pureed foods |
30 |
| With dietary
restrictions to soft and semi-solid foods |
20 |
| Without dietary
restrictions to mechanically altered foods |
10 |
| Lateral
excursion range of motion: |
|
| 0 to 4 mm |
10 |
| Note (1): Ratings
for limited interincisal movement shall not be combined with
ratings for limited lateral excursion |
|
| Note (2): For VA
compensation purposes, the normal maximum unassisted range of
vertical jaw opening is from 35 to 50 mm |
|
| Note (3): For VA
compensation purposes, mechanically altered foods are defined as
altered by blending, chopping, grinding or mashing so that they are
easy to chew and swallow. There are four levels of mechanically
altered foods: full liquid, puree, soft, and semisolid foods. To
warrant elevation based on mechanically altered foods, the use of
texture-modified diets must be recorded or verified by a
physician |
|
| 9908 Condyloid
process, loss of, one or both sides |
30 |
| 9909 Coronoid
process, loss of: |
|
| Bilateral |
20 |
| Unilateral |
10 |
| 9911 Hard palate,
loss of: |
|
| Loss of half or
more, not replaceable by prosthesis |
30 |
| Loss of less
than half, not replaceable by prosthesis |
20 |
| Loss of half or
more, replaceable by prosthesis |
10 |
| Loss of less
than half, replaceable by prosthesis |
0 |
| 9913 Teeth, loss
of, due to loss of substance of body of maxilla or mandible without
loss of continuity: |
|
| Where the lost
masticatory surface cannot be restored by suitable prosthesis: |
|
| Loss of all
teeth |
40 |
| Loss of all
upper teeth |
30 |
| Loss of all
lower teeth |
30 |
| All upper and
lower posterior teeth missing |
20 |
| All upper and
lower anterior teeth missing |
20 |
| All upper
anterior teeth missing |
10 |
| All lower
anterior teeth missing |
10 |
| All upper and
lower teeth on one side missing |
10 |
| Where the loss
of masticatory surface can be restored by suitable prosthesis |
0 |
| Note - These
ratings apply only to bone loss through trauma or disease such as
osteomyelitis, and not to the loss of the alveolar process as a
result of periodontal disease, since such loss is not considered
disabling |
|
| 9914 Maxilla, loss
of more than half: |
|
| Not replaceable
by prosthesis |
100 |
| Replaceable by
prosthesis |
50 |
| 9915 Maxilla, loss
of half or less: |
|
| Loss of 25 to
50 percent: |
|
| Not replaceable
by prosthesis |
40 |
| Replaceable by
prosthesis |
30 |
| Loss of less
than 25 percent: |
|
| Not replaceable
by prosthesis |
20 |
| Replaceable by
prosthesis |
0 |
| 9916 Maxilla,
malunion or nonunion of: |
|
| Nonunion, |
|
| With false
motion |
30 |
| Without false
motion |
10 |
| Malunion, |
|
| With
displacement, causing severe anterior or posterior open bite |
30 |
| With
displacement, causing moderate anterior or posterior open bite |
10 |
| With
displacement, causing mild anterior or posterior open bite |
0 |
| Note: For VA
compensation purposes, the severity of maxillary nonunion is
dependent upon the degree of abnormal mobility of maxilla fragments
following treatment (i.e., presence or absence of false motion),
and maxillary nonunion must be confirmed by diagnostic imaging
studies |
|
| 9917 Neoplasm,
hard and soft tissue, benign: |
|
| Rate as loss of
supporting structures (bone or teeth) and/or functional impairment
due to scarring. |
|
| 9918 Neoplasm,
hard and soft tissue, malignant |
100 |
| Note: A rating of
100 percent shall continue beyond the cessation of any surgical,
radiation, antineoplastic chemotherapy or other therapeutic
procedure. Six months after discontinuance of such treatment, the
appropriate disability rating shall be determined by mandatory VA
examination. Any change in evaluation based upon that or any
subsequent examination shall be subject to the provisions of §
3.105(e) of this chapter. If there has been no local recurrence or
metastasis, rate on residuals such as loss of supporting structures
(bone or teeth) and/or functional impairment due to scarring |
|